Receptor-interacting protein kinase 2 (RIPK2) stabilizes c-Myc and is a therapeutic target in prostate cancer metastasis.

Yan Y, Zhou B, Qian C, Vasquez A, Kamra M, Chatterjee A, Lee YJ, Yuan X, Ellis L, Di Vizio D, Posadas EM, Kyprianou N, Knudsen BS, Shah K, Murali R, Gertych A, You S, Freeman MR, Yang W
Nat Commun. 2022 Feb 3;13(1):669. doi: 10.1038/s41467-022-28340-6. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.